Trial Outcomes & Findings for Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising (NCT NCT00363038)
NCT ID: NCT00363038
Last Updated: 2021-12-03
Results Overview
Mean change in bruising level detected by dermatologist rater on Visual Analogue Scale at 2 weeks compared with baseline for each of the four agents (Petrolatum USP, Vitamin K and retinol ointment, Vitamin K ointment, Arnica ointment). When responding to a VAS item, respondents specify the bruise severity by indicating a position along a continuous line between two end-points (0 and 10, 10 being the most bruised).
COMPLETED
NA
16 participants
Baseline and 2 weeks
2021-12-03
Participant Flow
Subjects were recruited at a university-based dermatology department in an urban center.
Participant milestones
| Measure |
Average Bruise Improvement
pulsed dye laser induced four 1 cm bruises at least 5 cm apart on the skin of the upper arm (two bruises on each arm). Subjects applied different topical ointments on each of their bruises twice a day. Ointments were: 5% vitamin K cream; 1% vitamin K and 0.3% retinol cream; 20% topical arnica; white petrolatum United States Pharmacopeia (USP) as placebo.
|
|---|---|
|
Overall Study
STARTED
|
16
|
|
Overall Study
COMPLETED
|
16
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising
Baseline characteristics by cohort
| Measure |
Average Bruise Improvement
n=16 Participants
pulsed dye laser induced four 1 cm bruises at least 5 cm apart on the skin of the upper arm (two bruises on each arm). Subjects applied different topical ointments on each of their bruises twice a day. Ointments were: 5% vitamin K cream; 1% vitamin K and 0.3% retinol cream; 20% topical arnica; white petrolatum USP as placebo.
|
|---|---|
|
Age, Continuous
|
26 years
n=93 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=93 Participants
|
|
Region of Enrollment
United States
|
16 participants
n=93 Participants
|
PRIMARY outcome
Timeframe: Baseline and 2 weeksMean change in bruising level detected by dermatologist rater on Visual Analogue Scale at 2 weeks compared with baseline for each of the four agents (Petrolatum USP, Vitamin K and retinol ointment, Vitamin K ointment, Arnica ointment). When responding to a VAS item, respondents specify the bruise severity by indicating a position along a continuous line between two end-points (0 and 10, 10 being the most bruised).
Outcome measures
| Measure |
Average Bruise Improvement
n=16 Participants
pulsed dye laser induced four 1 cm bruises at least 5 cm apart on the skin of the upper arm (two bruises on each arm). Subjects applied different topical ointments on each of their bruises twice a day. Ointments were: 5% vitamin K cream; 1% vitamin K and 0.3% retinol cream; 20% topical arnica; white petrolatum USP as placebo.
|
|---|---|
|
Average Bruise Change
Petrolatum USP
|
-3.68 Units on a Scale
Standard Deviation 0.68 • Interval -10.0 to 10.0
|
|
Average Bruise Change
Vitamin K and retinol ointment
|
-3.71 Units on a Scale
Standard Deviation 0.60 • Interval -10.0 to 10.0
|
|
Average Bruise Change
Vitamin K ointment
|
-3.88 Units on a Scale
Standard Deviation 0.71 • Interval -10.0 to 10.0
|
|
Average Bruise Change
Arnica ointment
|
-4.13 Units on a Scale
Standard Deviation 0.84 • Interval -10.0 to 10.0
|
Adverse Events
Average Bruise Improvement
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Average Bruise Improvement
n=16 participants at risk
pulsed dye laser induced four 1 cm bruises at least 5 cm apart on the skin of the upper arm (two bruises on each arm). Subjects applied different topical ointments on each of their bruises twice a day. Ointments were: 5% vitamin K cream; 1% vitamin K and 0.3% retinol cream; 20% topical arnica; white petrolatum USP as placebo.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Redness and swelling at the treated sites
|
25.0%
4/16 • Number of events 4 • 2 weeks
|
|
Skin and subcutaneous tissue disorders
Blistering
|
6.2%
1/16 • Number of events 1 • 2 weeks
|
Additional Information
Murad Alam, MD
Northwestern University Department of Dermatology
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place